IL288982A - Macrocyclic kinase inhibitor polymorphs - Google Patents
Macrocyclic kinase inhibitor polymorphsInfo
- Publication number
- IL288982A IL288982A IL288982A IL28898221A IL288982A IL 288982 A IL288982 A IL 288982A IL 288982 A IL288982 A IL 288982A IL 28898221 A IL28898221 A IL 28898221A IL 288982 A IL288982 A IL 288982A
- Authority
- IL
- Israel
- Prior art keywords
- polymorphs
- kinase inhibitor
- macrocyclic kinase
- macrocyclic
- inhibitor
- Prior art date
Links
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962863493P | 2019-06-19 | 2019-06-19 | |
| US202062959940P | 2020-01-11 | 2020-01-11 | |
| US202063036102P | 2020-06-08 | 2020-06-08 | |
| PCT/US2020/037892 WO2020257169A1 (en) | 2019-06-19 | 2020-06-16 | Polymorphs of a macrocyclic kinase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL288982A true IL288982A (en) | 2022-02-01 |
Family
ID=74040102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL288982A IL288982A (en) | 2019-06-19 | 2021-12-14 | Macrocyclic kinase inhibitor polymorphs |
Country Status (15)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113336774B (zh) * | 2021-06-25 | 2023-05-23 | 江南大学 | 作为trk抑制剂的取代的手性二芳基大环化合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015112806A2 (en) * | 2014-01-24 | 2015-07-30 | Tp Therapeutics, Inc. | Diaryl macrocycles as modulators of protein kinases |
| RU2732405C2 (ru) * | 2015-07-02 | 2020-09-16 | Тёрнинг Поинт Терапьютикс, Инк. | Хиральные диарильные макроциклы в качестве модуляторов протеинкиназ |
| BR112018000297A2 (pt) * | 2015-07-06 | 2018-09-04 | Tp Therapeutics Inc | polimorfo de macrociclo de diarila |
| WO2017015367A1 (en) * | 2015-07-21 | 2017-01-26 | Tp Therapeutics, Inc. | Chiral diaryl macrocycles and uses thereof |
| CA3069554A1 (en) * | 2017-07-14 | 2019-01-17 | Glaxosmithkline Intellectual Property Development Limited | Inhibitors of leucine rich repeat kinase 2 |
| RS63787B1 (sr) * | 2017-12-19 | 2022-12-30 | Turning Point Therapeutics Inc | Makrociklična jedinjenja za lečenje bolesti |
-
2020
- 2020-06-16 WO PCT/US2020/037892 patent/WO2020257169A1/en not_active Ceased
- 2020-06-16 MX MX2021015756A patent/MX2021015756A/es unknown
- 2020-06-16 US US17/618,060 patent/US20220411439A1/en not_active Abandoned
- 2020-06-16 JP JP2021575515A patent/JP2022537385A/ja not_active Withdrawn
- 2020-06-16 AU AU2020294627A patent/AU2020294627A1/en not_active Abandoned
- 2020-06-16 PH PH1/2021/553174A patent/PH12021553174A1/en unknown
- 2020-06-16 KR KR1020227001994A patent/KR20220046549A/ko not_active Ceased
- 2020-06-16 EP EP20826665.0A patent/EP3986413A4/en not_active Withdrawn
- 2020-06-16 CA CA3143043A patent/CA3143043A1/en active Pending
- 2020-06-16 BR BR112021025786A patent/BR112021025786A2/pt not_active Application Discontinuation
- 2020-06-16 PE PE2021002184A patent/PE20220135A1/es unknown
- 2020-06-16 CN CN202080044953.1A patent/CN114025765A/zh active Pending
- 2020-06-19 TW TW109120778A patent/TW202115090A/zh unknown
-
2021
- 2021-12-14 IL IL288982A patent/IL288982A/en unknown
-
2022
- 2022-01-19 CO CONC2022/0000405A patent/CO2022000405A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12021553174A1 (en) | 2022-08-01 |
| WO2020257169A1 (en) | 2020-12-24 |
| MX2021015756A (es) | 2022-01-27 |
| AU2020294627A1 (en) | 2022-02-17 |
| PE20220135A1 (es) | 2022-01-27 |
| JP2022537385A (ja) | 2022-08-25 |
| BR112021025786A2 (pt) | 2022-02-01 |
| KR20220046549A (ko) | 2022-04-14 |
| CA3143043A1 (en) | 2020-12-24 |
| TW202115090A (zh) | 2021-04-16 |
| EP3986413A4 (en) | 2023-06-14 |
| CN114025765A (zh) | 2022-02-08 |
| CO2022000405A2 (es) | 2022-04-29 |
| US20220411439A1 (en) | 2022-12-29 |
| EP3986413A1 (en) | 2022-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL292644B1 (en) | RAS inhibitors | |
| IL286102A (en) | macrocyclic compounds | |
| EP3783000A4 (en) | MACROCYCLIC KINASE INHIBITOR | |
| GB201914860D0 (en) | Inhibitor compounds | |
| GB202008201D0 (en) | Inhibitor compounds | |
| IL290087A (en) | inhibitory substances | |
| SMT202500291T1 (it) | Forme solide di un promotore di spinogenesi | |
| GB202013721D0 (en) | New compounds | |
| GB202015585D0 (en) | New compounds | |
| GB202004960D0 (en) | Inhibitor compounds | |
| GB201905328D0 (en) | Inhibitor compounds | |
| GB202110373D0 (en) | Inhibitor compounds | |
| GB201917867D0 (en) | Polymorphs | |
| IL297684B1 (en) | Processes for preparing a kinase inhibitor | |
| IL285427A (en) | Crystal forms of jak2 inhibitor | |
| EP3986413A4 (en) | POLYMORPHS OF A MACROCYCLIC KINASE INHIBITOR | |
| IL284564A (en) | Polymorphic forms of a modified quinoline-type bridged piperidine compound | |
| HK40073322A (en) | Polymorphs of a macrocyclic kinase inhibitor | |
| IL291368A (en) | Inhibits expression of methadherin | |
| GB202117224D0 (en) | Inhibitor compounds | |
| GB202012969D0 (en) | Inhibitor compounds | |
| IL294503B1 (en) | Polymorphs of Alfibrinnor | |
| GB202112240D0 (en) | Inhibitor compounds | |
| GB202107325D0 (en) | Inhibitor compounds | |
| GB202104781D0 (en) | Inhibitor compounds |